Emily Singer

A View from Emily Singer

Will Ozzy's Genome Reveal the Secret of Rock Star Resilience?

The infamous rock star is paying Cambridge-based Knome to sequence his genome.

  • June 22, 2010

Last week, my brother informed me of some strange genome news he had heard on his favorite morning radio show. Ozzy Osbourne, front man for Black Sabbath, is going to have his genome sequenced in order to figure out how he is still alive after decades of legendary drug use. Blogs were a-twitter with the cryptic news, but yesterday the Toronto Star published a much more informative and sensible piece.

Osbourne is paying Knome, a start-up here in Cambridge, to sequence his genome. (The company charges about $19,000 to sequence just the protein-coding region of the genome and approximately three times that amount for the full genome.) Nathaniel Pearson, Knome’s director of research, speculated to the Star that Ozzy “was spurred to sequence his genome by his new gig as a health columnist for the Sunday Times of London. (According to the Star, he’s written two so far, “riffing on syphilis, euthanasia and the laxative effects of spicy food.”)

Ozzy is likely over optimistic if he thinks his genome will reveal the secret of his resilience. Too little is known about the vast majority of the human genome. But there may be some clues.

“Ozzy may in fact share gene variants with people who may be able to metabolize recreational drugs better than others,” Pearson told the Star on Monday…Given the high sensitivity of liver genes to revealing how the body deals with drugs and alcohol, Osbourne’s results might be a revelation.”We may find something,” said Pearson. “We probably won’t. Not today. I want to tamp down expectations.”

“By all accounts, I’m a medical miracle,” Osbourne wrote in his introduction to the Dr. Ozzy Osbourne column. “I was knocking back four bottles of cognac a day. While filming The Osbournes, I was shoving 42 types of prescription medication down my neck, and that was before all the dope I was smoking.

“And then there was the rabies treatment I had to go through after eating a bat.”

The latest Insider Conversation is live! Listen to the story behind the story.

Subscribe today
Already a Premium subscriber? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Premium.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look: exclusive early access to important stories, before they’re available to anyone else

    Insider Conversations: listen in on in-depth calls between our editors and today’s thought leaders

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.